Results: 21
FDA grants accelerated approval for targeted therapy for platinum‐resistant gynecologic cancers.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 656, doi. 10.1002/cncr.34670
- By:
- Publication type:
- Article
Association of physical exercise and a healthy gut microbiome in colorectal cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 655, doi. 10.1002/cncr.34669
- By:
- Publication type:
- Article
Global system for cancer drug testing and approval is needed: Creating a global regulatory system could save millions of lives by improving the time to therapy for patients with cancer throughout the world.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 654, doi. 10.1002/cncr.34668
- By:
- Publication type:
- Article
Erratum to "Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 807, doi. 10.1002/cncr.34638
- Publication type:
- Article
Global cancer surgery in low‐resource settings: A strengths, weaknesses, opportunities, and threats analysis.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 671, doi. 10.1002/cncr.34630
- By:
- Publication type:
- Article
Top advances of the year: Cervical cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 657, doi. 10.1002/cncr.34617
- By:
- Publication type:
- Article
Spatial PD‐L1, immune‐cell microenvironment, and genomic copy‐number alteration patterns and drivers of invasive‐disease transition in prospective oral precancer cohort.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 714, doi. 10.1002/cncr.34607
- By:
- Publication type:
- Article
Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 790, doi. 10.1002/cncr.34606
- By:
- Publication type:
- Article
Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 780, doi. 10.1002/cncr.34600
- By:
- Publication type:
- Article
Survivorship experience: More than premature mortality from cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 803, doi. 10.1002/cncr.34583
- By:
- Publication type:
- Article
Cancer trials as opportunities to serve and learn from individuals with human immunodeficiency virus.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 664, doi. 10.1002/cncr.34598
- By:
- Publication type:
- Article
The importance of body composition in patients with prostate cancer receiving radiotherapy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 668, doi. 10.1002/cncr.34594
- By:
- Publication type:
- Article
The association of race/ethnicity in male breast cancer survival within similar comorbidity cohorts.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 750, doi. 10.1002/cncr.34592
- By:
- Publication type:
- Article
Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 764, doi. 10.1002/cncr.34574
- By:
- Publication type:
- Article
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 697, doi. 10.1002/cncr.34582
- By:
- Publication type:
- Article
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 685, doi. 10.1002/cncr.34596
- By:
- Publication type:
- Article
Reply to "Survivorship experience: More than premature mortality from cancer".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 805, doi. 10.1002/cncr.34581
- By:
- Publication type:
- Article
Impact of S‐1 adjuvant chemotherapy longer than 6 months on survival in patients with resected pancreatic cancer: a nationwide survey by the Japan Pancreas Society based on real‐world data.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 728, doi. 10.1002/cncr.34580
- By:
- Publication type:
- Article
Phase 2 prospective open label study of neoadjuvant nab‐paclitaxel, trastuzumab, and pertuzumab in patients with HER2‐positive primary breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 740, doi. 10.1002/cncr.34589
- By:
- Publication type:
- Article
How should childhood acute lymphoblastic leukemia relapses in low‐income and middle‐income countries be managed: The AHOPCA‐ALL study group experience.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 771, doi. 10.1002/cncr.34572
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 5, p. 647, doi. 10.1002/cncr.33701
- Publication type:
- Article